ArticleTranslational cancer research2024
Development of prediction models for liver metastasis in colorectal cancer based on machine learning: a population-level study.
Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Machine learning for predicting liver metastasis in colorectal cancer.Discover oncology · 2026Article
- An Interpretable Machine Learning Model Based on Inflammatory-Nutritional Biomarkers for Predicting Metachronous Liver Metastases After Colorectal Cancer Surgery.Biomedicines · 2025Article
- Optimizing prediction of metastasis among colorectal cancer patients using machine learning technology.BMC gastroenterology · 2025Article
- Construction of a postoperative liver metastasis prediction model for colorectal cancer based on spectral CT imaging, CEA, and CA19-9.Translational cancer research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver metastasis (LM) is of vital importance in making treatment-related decisions in patients with colorectal cancer (CRC). The aim of our study was to develop and validate prediction models for LM in CRC by making use of machine learning. Methods: We selected patients diagnosed with CRC from 2010 to 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. Four machine-learning methods, eXtreme gradient boost (XGB), decision tree (DT), random forest (RF), and support vector machine (SVM), were employed to develop a predictive model. The receiver operating characteristic (ROC) curves, decision curve analysis (DCA) curves and calibration curves were adopted to evaluate the model performance. The SHapley Additive exPlanation (SHAP) technique was chosen for visual analysis to enhance the interpretation of the outcomes of models. Results: A total of 51,632 patients suffering from CRC were selected from the SEER database. Excellent accuracy of machine learning models was showed from ROC curves. In both the training and validation cohorts, calibration curves for the likelihood of LM demonstrated a high degree of concordance between model prediction and actual observation. The DCA indicated that each machine learning model can yield net benefits for both treat-none and treat-all strategies. Carcinoembryonic antigen (CEA) and N stage were identified as the most significant risk factors for LM based on the SHAP summary plot of the RF and XGB models. Conclusions: The XGB and RF were the best machine learning models among the four algorithms, of which CEA and N stage were identified as the most important risk factors related to LM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.